Meijuan Huang Selected Research

osimertinib

6/2022	Response to Pralsetinib Observed in Meningeal-Metastatic EGFR-Mutant NSCLC With Acquired RET Fusion: A Brief Report.
1/2021	Case Report: Outcome of Osimertinib Treatment in Lung Adenocarcinoma Patients With Acquired KRAS Mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meijuan Huang Research Topics

Disease

34	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2010
27	Neoplasms (Cancer) 03/2024 - 04/2005
11	Adenocarcinoma of Lung 02/2024 - 07/2014
10	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2017
6	Disease Progression 11/2022 - 08/2013
5	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2016
5	Colonic Neoplasms (Colon Cancer) 07/2023 - 01/2011
5	Hemorrhage 03/2023 - 01/2017
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2020 - 07/2009
3	Infections 02/2024 - 02/2017
3	Hemophilia A (Haemophilia) 01/2023 - 12/2019
3	Lung Neoplasms (Lung Cancer) 04/2020 - 07/2014
2	Melanoma (Melanoma, Malignant) 03/2024 - 01/2019
2	Hemolysis 02/2024 - 01/2013
2	Lymphoma (Lymphomas) 02/2024 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 07/2017
2	Inflammation (Inflammations) 12/2022 - 01/2018
2	Hand-Foot Syndrome 01/2022 - 01/2020
2	Diarrhea 02/2021 - 08/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Esophageal Squamous Cell Carcinoma 01/2020 - 09/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 11/2012
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2016 - 10/2015
2	Leukemia 02/2015 - 04/2005
1	Necrosis 03/2024
1	Malignant Pleural Effusion 02/2024
1	Malignant Mesothelioma 02/2024
1	Exanthema (Rash) 04/2023
1	Hemophilia B (Haemophilia B) 01/2023

Drug/Important Bio-Agent (IBA)

13	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2015
12	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
12	ErbB Receptors (EGF Receptor)IBA 04/2024 - 05/2005
5	Pemetrexed (MTA)FDA Link 01/2023 - 07/2014
4	Inosine Triphosphate (ITP)IBA 12/2023 - 01/2017
4	CytokinesIBA 01/2023 - 01/2017
4	Phosphotransferases (Kinase)IBA 01/2022 - 07/2014
4	Anaplastic Lymphoma KinaseIBA 12/2021 - 07/2014
4	CrizotinibIBA 09/2020 - 07/2014
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2018
3	ceritinibIBA 04/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2019 - 07/2009
2	Bevacizumab (Avastin)FDA Link 02/2024 - 04/2018
2	Ceruloplasmin (Ferroxidase)IBA 07/2023 - 01/2016
2	anlotinibIBA 04/2023 - 01/2022
2	rezivertinibIBA 01/2023 - 11/2022
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2021
2	Peptides (Polypeptides)IBA 12/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 12/2022 - 01/2021
2	osimertinibIBA 06/2022 - 01/2021
2	eltrombopag FDA Link 01/2022 - 01/2017
2	PlatinumIBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 02/2018
2	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 12/2019
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2020
2	AntigensIBA 01/2020 - 04/2005
2	nasIBA 10/2019 - 01/2019
2	ProdrugsIBA 10/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2016
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018 - 11/2012
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2015 - 01/2013
2	MicellesIBA 01/2013 - 11/2012
1	lyseninIBA 03/2024
1	AminesIBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	isoxanthohumolIBA 02/2024
1	Vancomycin FDA LinkGeneric 02/2024
1	AsbestosIBA 02/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024
1	ThiazolesIBA 01/2024
1	C-Reactive ProteinIBA 12/2023
1	thrombopoietin mimetic peptideIBA 12/2023
1	romiplostim FDA Link 12/2023
1	Biosimilar PharmaceuticalsIBA 12/2023
1	sintilimabIBA 10/2023
1	human ERBB2 proteinIBA 04/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2023
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2023
1	LigandsIBA 01/2023
1	SmokeIBA 01/2023
1	SolutionsIBA 12/2022
1	sym-trinitrobenzeneIBA 12/2022
1	EnrofloxacinIBA 12/2022
1	Sulfonic AcidsIBA 12/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022
1	GlucocorticoidsIBA 11/2022
1	pralsetinibIBA 06/2022
1	MethyltransferasesIBA 01/2022

Therapy/Procedure

28	Therapeutics 03/2024 - 01/2011
10	Drug Therapy (Chemotherapy) 02/2024 - 06/2012
9	Immunotherapy 04/2024 - 01/2020
9	Radiotherapy 12/2023 - 06/2012
3	Chemoradiotherapy 01/2020 - 06/2010
2	Esophagectomy 01/2020 - 06/2012
2	Transplantation 01/2016 - 10/2015
2	Salvage Therapy 06/2012 - 01/2012
1	Oral Administration 12/2022